Plenary Panel | Monday, April 24 | 3:30 – 4:30 p.m. ET
Laura Adams, Special Advisor at the National Academy of Medicine (NAM), provides leadership for the NAM Digital Health and Evidence Mobilization portfolios of the Leadership Consortium. Her primary expertise is in digital health, biotech, and human-centered care. She serves on the boards of Boston-based T2 Biosystems, Translational Medicine Accelerator (TMA), and is a member of the Oversight Council for the Massachusetts Center for Health Information and Analysis. She is also an advisor for Inflammatix, a Burlingame, California-based biotech company specializing in transcriptomics.
Previously, Laura was the founding President and CEO of the Rhode Island Quality Institute (RIQI), Rhode Island’s statewide Health Information Exchange. During her time at RIQI, Health Data Management named her one of their 2018 Most Powerful Women in Health IT in the Thought Leader category and Becker’s Hospital Review named her to the 2018 inaugural list of Female Health IT Leaders to Know and to the 2019 list of Women in Health IT to Know. As Catalyst at X4 Health, Laura led the national strategic partnerships for the 3rd Conversation (3C) project, helping to reweave humanity into the fabric of healthcare and healing.
Laura was also Founder, President, and CEO of Decision Support Systems, a New York-based company specializing in Internet-based healthcare decision support. She has been a long-time faculty member of the Institute for Healthcare Improvement (IHI) in Boston. She directed the IHI Idealized Design of the Intensive Care Unit project and served as faculty in the VHA’s ICU improvement collaborative and was the Principal Investigator on the RI Statewide ICU Collaborative. She was among the first to bring the principles of healthcare QI to the Middle East, in conjunction with Donald Berwick, MD and the Harvard Institute for Social and Economic Policy in the Middle East. She served as IHI faculty at the inaugural IHI Middle East Forum on Quality Improvement in Healthcare in Doha, Qatar.